Jozefien Declercq

1.2k total citations
6 papers, 93 citations indexed

About

Jozefien Declercq is a scholar working on Infectious Diseases, Molecular Biology and Immunology and Allergy. According to data from OpenAlex, Jozefien Declercq has authored 6 papers receiving a total of 93 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 2 papers in Molecular Biology and 2 papers in Immunology and Allergy. Recurrent topics in Jozefien Declercq's work include COVID-19 Clinical Research Studies (2 papers), Allergic Rhinitis and Sensitization (2 papers) and Long-Term Effects of COVID-19 (1 paper). Jozefien Declercq is often cited by papers focused on COVID-19 Clinical Research Studies (2 papers), Allergic Rhinitis and Sensitization (2 papers) and Long-Term Effects of COVID-19 (1 paper). Jozefien Declercq collaborates with scholars based in Belgium, Netherlands and Spain. Jozefien Declercq's co-authors include Bart N. Lambrecht, Elisabeth De Leeuw, Gabriële Holtappels, Claus Bachert, Ursula Smole, Cédric Bosteels, Victor Bosteels, Pieter Depuydt, Simon J. Tavernier and Bastiaan Maes and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Science Translational Medicine and Frontiers in Immunology.

In The Last Decade

Jozefien Declercq

6 papers receiving 92 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jozefien Declercq Belgium	5	52	27	18	15	15	6	93
Gökhan Aytekіn Türkiye	5	45 0.9×	28 1.0×	11 0.6×	8 0.5×	7 0.5×	28	98
Selina Gierer United States	5	34 0.7×	29 1.1×	5 0.3×	13 0.9×	17 1.1×	16	99
Fatih Çölkesen Türkiye	6	31 0.6×	26 1.0×	11 0.6×	5 0.3×	8 0.5×	45	109
Tomoyuki Kimura Japan	5	26 0.5×	14 0.5×	11 0.6×	43 2.9×	7 0.5×	10	88
Alejandro Nieto-Patlán United States	6	40 0.8×	53 2.0×	5 0.3×	14 0.9×	13 0.9×	8	87
Amalia Tejeda Velarde Spain	6	63 1.2×	95 3.5×	18 1.0×	6 0.4×	30 2.0×	24	168
M. Sabri Hamad Cyprus	2	52 1.0×	11 0.4×	6 0.3×	4 0.3×	15 1.0×	2	75
Marco Sita Italy	3	35 0.7×	25 0.9×	21 1.2×	2 0.1×	10 0.7×	3	72
Lucie Rodriguez Sweden	3	91 1.8×	45 1.7×	44 2.4×	18 1.2×	32 2.1×	9	151
Dana Bohan United States	5	85 1.6×	39 1.4×	12 0.7×	5 0.3×	33 2.2×	6	139

Countries citing papers authored by Jozefien Declercq

Since Specialization

Citations

This map shows the geographic impact of Jozefien Declercq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jozefien Declercq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jozefien Declercq more than expected).

Fields of papers citing papers by Jozefien Declercq

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jozefien Declercq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jozefien Declercq. The network helps show where Jozefien Declercq may publish in the future.

Co-authorship network of co-authors of Jozefien Declercq

This figure shows the co-authorship network connecting the top 25 collaborators of Jozefien Declercq. A scholar is included among the top collaborators of Jozefien Declercq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jozefien Declercq. Jozefien Declercq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Declercq, Jozefien, Sarah Gerlo, Natalie De Ruyck, et al.. (2024). Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosa. Science Translational Medicine. 16(770). eadn2364–eadn2364. 8 indexed citations

2.

Declercq, Jozefien, Hamida Hammad, Bart N. Lambrecht, & Ursula Smole. (2023). Chitinases and chitinase-like proteins in asthma. Seminars in Immunology. 67. 101759–101759. 6 indexed citations

3.

Declercq, Jozefien, et al.. (2022). Granulocyte-colony stimulating factor: Missing link for stratification of type 2–high and type 2–low chronic rhinosinusitis patients. Journal of Allergy and Clinical Immunology. 149(5). 1655–1665.e5. 15 indexed citations

4.

Declercq, Jozefien, Elisabeth De Leeuw, & Bart N. Lambrecht. (2022). Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: from prognostic marker to therapeutic agent. Cytokine. 157. 155934–155934. 24 indexed citations

5.

Declercq, Jozefien, Stijn Vanhee, Bart N. Lambrecht, et al.. (2022). RNA viruses alter house dust mite physiology and allergen production with no detected consequences for allergenicity. Insect Molecular Biology. 32(2). 173–186. 2 indexed citations

6.

Damme, Karel Van, Simon J. Tavernier, Elisabeth De Leeuw, et al.. (2020). Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19. Frontiers in Immunology. 11. 596761–596761. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact